Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Caligiuri

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Dalton Transactions (Cambridge, England : 2003)|September 13, 2018
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activities on human ovarian cancer cell linesThomas Scattolin, Isabella Caligiuri, Luciano Canovese, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 23, 2017
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitorsCarlotta Granchi, Isabella Caligiuri, Eleonora Bertelli, et al.
Nanomedicine (London, England)|October 1, 2015
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicinGiuseppe Toffoli, Mohamad Hadla, Giuseppe Corona, et al.
RSC Advances|August 23, 2024
Biodegradation of hydroxylated boron nitride nanoplatelets, their toxic effect and drug delivery applicationKanwal Asif, Md Mahbubur Rahman, Andrea Augusto Sfriso, et al.
Dalton Transactions (Cambridge, England : 2003)|April 22, 2024
Dinuclear NHC-gold(I)-thiolato and -alkynyl complexes: synthesis, anticancer activity, and catalytic activity in lactonization reactionsXinyuan Ma, Yuan Zhao, Isabella Caligiuri, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 12, 2018
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitorsGiulio Poli, Margherita Lapillo, Carlotta Granchi, et al.
Journal of Chemical Information and Modeling|September 5, 2013
Identification of new Fyn kinase inhibitors using a FLAP-based approachGiulio Poli, Tiziano Tuccinardi, Flavio Rizzolio, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 31, 2019
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitorsGiulio Poli, Margherita Lapillo, Vibhu Jha, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2024
Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulationKanwal Asif, Muhammad Adeel, Md Mahbubur Rahman, et al.
Frontiers in Pharmacology|February 7, 2019
A Guide to PIN1 Function and Mutations Across CancersMaguie El Boustani, Lucia De Stefano, Isabella Caligiuri, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Dalton Transactions (Cambridge, England : 2003)|September 13, 2018
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activities on human ovarian cancer cell linesThomas Scattolin, Isabella Caligiuri, Luciano Canovese, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 23, 2017
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitorsCarlotta Granchi, Isabella Caligiuri, Eleonora Bertelli, et al.
Nanomedicine (London, England)|October 1, 2015
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicinGiuseppe Toffoli, Mohamad Hadla, Giuseppe Corona, et al.
RSC Advances|August 23, 2024
Biodegradation of hydroxylated boron nitride nanoplatelets, their toxic effect and drug delivery applicationKanwal Asif, Md Mahbubur Rahman, Andrea Augusto Sfriso, et al.
Dalton Transactions (Cambridge, England : 2003)|April 22, 2024
Dinuclear NHC-gold(I)-thiolato and -alkynyl complexes: synthesis, anticancer activity, and catalytic activity in lactonization reactionsXinyuan Ma, Yuan Zhao, Isabella Caligiuri, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 12, 2018
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitorsGiulio Poli, Margherita Lapillo, Carlotta Granchi, et al.
Journal of Chemical Information and Modeling|September 5, 2013
Identification of new Fyn kinase inhibitors using a FLAP-based approachGiulio Poli, Tiziano Tuccinardi, Flavio Rizzolio, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 31, 2019
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitorsGiulio Poli, Margherita Lapillo, Vibhu Jha, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2024
Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulationKanwal Asif, Muhammad Adeel, Md Mahbubur Rahman, et al.
Frontiers in Pharmacology|February 7, 2019
A Guide to PIN1 Function and Mutations Across CancersMaguie El Boustani, Lucia De Stefano, Isabella Caligiuri, et al.
Pageof 8